New hope for metastatic melanoma patients – Weill Cornell Medicine Meyer Cancer

Weill Cornell Medicine Meyer Cancer Center shared a post by Weill Cornell Medicine on X, adding the following:

“Check out the latest research from WCM Meyer Cancer Director Dr. Jedd Wolchok and colleagues, providing hope for patients with metastatic melanoma.”

Quoting Weill Cornell Medicine’s post:

“About half of patients with metastatic melanoma treated with a combo of immune checkpoint inhibitors survive cancer-free for 10 years or more, according to new trial findings led by WCM Meyer Cancer, Dana Farber, and Royal Marsden NHS.

Full story.”

Source: Weill Cornell Medicine Meyer Cancer Center/X and Weill Cornell Medicine/X